Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

INO - INO - Historical Price Movements Surrounding Earnings

home / stock / ino / ino news

RSS
INO INO Quote INO Short INO News INO Articles INO Message Board
  • May, 12 2025 06:48 PM
  • |
  • KlickAnalytics

2025-05-12 18:48:12 ET

Inovio Pharmaceuticals, Inc. (INO) - This analysis reviews how the stock price reacted during the last 12 earnings periods.

  • The average open to high on the day of earnings was 5.44%.
  • The average open to low on the day of earnings was -7.92%.
  • The average open to close on the day of earnings was -1.13%.
  • For a 5-day holding period prior to earning announcements, INO shows a positive average return of 0.63%, with a 67% positive occurances.
  • For a 14-day holdi ...
    Full story available on KlickAnalytics.com

    • Get Email and Text Alerts for (NASDAQ:INO)

    Get Email and Text Alerts for (NASDAQ:INO)

    News, Short Squeeze, Breakout and More Instantly...

    Tags
    • $INO
    Share This Post

    Market Wire News is a media platform, the information on this page was provided by KlickAnalytics via Quote Media. Read our full disclaimer.

    Link your X Account to Market Wire News

    When you linking your X Account to Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

    Be alerted of any news about your stocks and see what other stocks are trending.

    Contact the Author

    Stock Information
    Get INO Alerts

    News, Short Squeeze, Breakout and More Instantly...

    Inovio Pharmaceuticals Inc. Company Name:

    INO Stock Symbol:

    NASDAQ Market:

    -1.38% G/L:

    $1.39 Last:

    2,577,813 Volume:

    $1.47 Open:

    $1.39 Close:

    Inovio Pharmaceuticals Inc. Website:

    Inovio Pharmaceuticals Inc. Logo

    Ad

    Investor Relations
    RECENT INO NEWS
    • INO - INOVIO Announces Pricing of $25 Million Public Offering

      INOVIO Announces Pricing of $25 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa. , July 3, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...

    • INO - Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

      LONDON and PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical Officer (CMO) and Yulii Bogatyrenko as an advisor ...

    • INO - INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

      INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights PR Newswire On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP) in mid-2025 ...

    •
    • Research
    • Stock Search
    • News Releases
    • Articles
    • Topics
    • Message Boards
    • Trending Stocks
    • Trending Feed
    • Trending Alerts
    • Watchlist
    • Short Information
    • Stock Wall
    • Link Twitter
    • Sign Up
    • Login
    • Contact

    Link your X Account

    Link your X Account to Market Wire News

    When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

    Be alerted of any news about your stocks and see what other stocks are trending.

    Connect with Us

    Join our Telegram Alerts Channel

    Telegram

    Join our Discord

    Discord

    Get INO Alerts

    Get INO Alerts

    News, Short Squeeze, Breakout and More Instantly...

    Sign up or login to continue

    Sign up or login to continue.

    Forgot password?


    Mobile Number Subscribers

    Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

    How to Opt Out

    To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

    Mobile Support

    For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

    Disclaimer

    This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

    Advertise

    Brand your company, advertise your products or services with our ad programs.

    Advertise

    Research

    Stock Search

    News Releases

    Articles

    Message Boards

    Trending Stocks

    Short Information

    Stock Wall

    Members

    Log In

    Sign Up

    Stay Connected

    | X

    | Facebook

    | BlueSky

    | LinkedIn

    | Telegram

    | Discord

    Contact

    Privacy

    Terms of Service

    Disclaimer

    © 2025 Market Wire News 1